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In recent years, considerable interest and research effort has been focused on the role 
of the major histocompatibility complex (MHC) ~ in the immune response. Interestingly, 
many of the characteristics of MHC genes and their products are shared by non-MHC 
(background) genes and their products.  In the mouse,  for example,  these include:  (a) 
the  ability  to  induce  graft  rejection  (1); (b)  the  ability  to  stimulate  lymphocyte 
proliferation  in  mixed  lymphocyte culture  (MLC)  (2); (c)  regulation  of the  antibody 
response to various antigens  (3-13),  which in some cases is linked to the heavy chain 
allotype  locus  (9-12)  or the  X-chromosome (5-7);  and  (d)  regulation of the  ability to 
produce (14) or accept (15) suppressor factors. 
Previous work from this laboratory has shown that some non-H-2 alloantigens,  like 
the Ia antigens determined by genes in the ]  region of the H-2 complex, are associated 
with  the  Fc receptors of B  lymphocytes (16). Thus,  antibodies  against  such  non-H-2 
alloantigens inhibited the binding of Ig complexes to B-cell Fc receptors. This inhibition 
was specific  in that the Fc portion of the alloantibodies was not required for inhibition 
(16), and antibodies against other lymphocyte surface antigens did not produce similar 
inhibition  (17). Presumably, anti-Ia antibodies and anti-non-H-2 alloantibodies inhibit 
the same receptors since no Fc receptors were detectable on B cells  after pretreatment 
with either reagent (16, 17). Preliminary data suggested that the Fc receptor-associated 
non-H-2 antigens were determined by a single gene locus  (16). 
The present studies were performed to further characterize the B-lymphocyte 
Fc receptor-associated non-H-2 antigens  and the  genes which determine  their 
expression. The data indicate: (a) the antigens are expressed primarily but not 
exclusively on B  cells and some evidence was obtained that these antigens are 
not identical to Fc receptors;  (b) the antigens are determined by a  single non- 
H-2 gene locus  in  the three  strains  (A/J,  B10,  and  CBA/J) that  were  tested, 
and the products of this single locus in at least two of the strains (B10 and CBA/J) 
share  antigenic  specificities;  (c)  the  locus  is  polymorphic and determines  the 
1Abbreviations  used  in  this  paper:  aggregated  Ig,  heat-aggregated  fluorescein-conjugated 
human Cohn fraction II immunoglobulin; BSA, bovine serum  albumin; FCS, fetal calf serum; 
fluorescein,  fluorescein isothiocyanate;  [~H]TdR, [3H]thymidine; Ir,  immune  response; MEM, 
Eagle's MEM without L-glutamine; MHC, major histocompatibility complex; MLC, mixed lym- 
phocyte culture; PBS, Na phosphate-(0.05 M) buffered saline; rhodamine, tetramethyl rhodamine 
isothiocyanate; SI, stimulation  index. 
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expression of at least four different antigens;  and (d) the locus is not linked to 
H-1  or the heavy chain allotype locus, but is linked to the Mls locus. 
Materials and Methods 
Animals.  Adult mice of strains C57BL/10Sn (B10), B10.A/SgSn, A/J,  C3H/HeJ,  and CBA/J 
were purchased from The Jackson Laboratory,  Bar Harbor,  Maine.  C3H/HeN  adult mice were 
obtained from the Division of Research Services of the National Institutes of Health, Bethesda, 
Md.  F1  mice B10.A  x  A/J,  A/J  x  B10.A,  and C3H/HeJ  x  CBA/J,  as  well as backcress mice 
(B10.A  x  A/J)F1  x  A/J, (A/J x  B10.A)F~ x  B10.A, and (C3H/HeJ  x  CBA/J)F1  x  C3H/HeJ were 
bred in our own facilities. 
Reagents.  Fluorescein isothiocyanate (fluorescein)-conjugated rabbit anti-mouse Ig (lot nos. 
7292  and  8354)  was  purchased  from  Cappel  Laboratories,  Inc.,  Downingtown,  Pa.  This  was 
dialyzed against phosphate (0.05 M)-buffered saline, pH 7.2 (PBS) and used at a  dilution of 1/8 in 
PBS.  Tetramethyl  rhodamine  isothiocyanate  (rhodamine)-conjugated goat  anti-rabbit Ig  was 
purchased from Cappel Laboratories (lot no. 7707). This was dialyzed against PBS, absorbed with 
Sepharose-coupled  normal  mouse  ascites  proteins,  and  used  at  a  dilution  of  1/8  in  PBS. 
Fluorescein-conjugated,  affinity-purified goat antibodies against mouse IgGi and IgG2 were the 
kind gifts of Dr.  R. Asofsky,  National Institutes of Health. These were used at concentrations, 
respectively,  of 0.5  mg/ml  and  0.125  mg/ml  in  PBS.  Fluorescein-conjugated,  heat-aggregated 
human Cohn fraction II (aggregated Ig) was prepared as previously described (18). Before use the 
aggregated Ig was titered on mouse spleen cells (see below: Fluorescence) and a  concentration 
was chosen that gave a  plateau value for the percentage of positive cells (generally 1-4 mg/ml). 
Soluble  rabbit  anti-trinitrephenol  (TNP)-TNP-bovine  serum  albumin  (BSA)  complexes  were 
prepared as previously described (19)  and were used at a  concentration of I  mg/ml in PBS. The 
affinity-purified rabbit IgG anti-TNF  used in these complexes was the kind gift of Dr.  P.  A. 
Henkart,  National Institutes of Health.  Alloantibodies were  prepared as previously  described 
(16, 20).  The alloantisera were decomplemented and used either undiluted or at dilutions which 
were on the plateau of cytotoxic killing for the strain of cells being tested (17). All reagents (except 
for rabbit anti-TNP-TNP-BSA  complexes  and aggregated  Ig)  were  ultracentrifuged to  remove 
complexes immediately before use (17).  Absorptions of alloantibodies with spleen cells were per- 
formed as previously described (20). 
Fluorescence.  Single cell suspensions from spleen were prepared as previously described (17), 
and  resuspended  in  2%  BSA  in  PBS  at  20  x  10e/ml.  Na  azide  (0.02%)  was  present  in  all 
experiments except where capping was performed. The BSA-PBS had a  pH of 7.2 except when it 
was used with aggregated Ig in which case the pH was 8.0.  For detection of lymphocyte surface 
Ig, 25 pl of the spleen cell suspension was mixed with 25/~l of the fluorescein-conjugated rabbit 
anti-mouse Ig, incubated 30 rain at 4°C, and washed three times with BSA-PBS. For detection of 
B-lymphocyte Fc receptors using aggregated Ig,  25 ~1 of the spleen cell suspension was mixed 
with 25 ~l of the aggregated Ig,  incubated 30 min at 23°C,  and washed three times with BSA- 
PBS.  For detection with antigen-antibody complexes,  25  ~l of the spleen cell suspension was 
mixed with  10  /~1 of rabbit anti-TNP-TNP-BSA  complexes and incubated 30 rain at 23°C.  The 
cells were washed three times with BSA-PBS and resuspended in 25/~1 of rhodamine-conjugated 
goat anti-rabbit Ig.  After 30 rain at 4°C the cells were washed three times with BSA-PBS. For 
detection of lymphocyte alloantigens, 25 pl of the spleen cell suspension was incubated with 100 
pl of the appropriate alloantibodies for 30 rain at 4°C.  The cells were washed three times with 
BSA-PBS and resuspended  in 25 /~I  of  fluorescein-conjugated  goat anti-mouse IgG2 and, in some 
experiments, 25 ~l of  fluorescein-conjugated  goat anti-mouse IgG~.  After 30 rain  at 4°C the cells 
were washed three times with BSA-PBS.  Preparation  of slides and visual microscopy for 
fluorescein  and rhodamine were performed as previously  described (17,  18). 
Inhibition Studies.  To assess inhibition of binding of aggregated Ig to B-cell Fc receptors by 
the alloantibodies being tested,  25  #tl of the spleen cell suspension was incubated in 100  pl of 
heat-inactivated alloantiserum for 30 rain at 4°C.  The cells were then washed three times with 
BSA-PBS and labeled with aggregated Ig as described above. 
Capping of B-Lymphocyte-Bound Antigen-Antibody  Complexes.  Cells were labeled with anti- 
gen-antibody complexes as described above except that no Na azide was present and the final 
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containing 10%  (vol/vol) heat-inactivated fetal calf serum (Grand Island Biological Co., Grand 
Island,  N.Y.,  lot no.  762218) (FCS).  The  cells were resuspended in  250  /~l  of MEM-FCS and 
incubated for 15 rain in a 37°C waterbath. The cells were then washed three times with BSA-PBS 
containing Na azide. 
Determination  of Immunoglobulin  Allotype.  The  anti-allotype  antisera  were  produced  by 
injecting anti-pertussis-pertussis complexes into inbred mice which were allotypically different 
as described by Herzenberg and Herzenberg (21). The Ouchterlony double diffusion technique 
was used to determine the allotypes of individual animals. 
Cytotoxicity.  Spleen cells were serologically typed by using a two-stage complement-mediated 
trypan-blue exclusion microcytotoxicity assay as previously described (22). 
Mixed Lymphocyte Reactions.  The techniques utilized have been described in detail (23, 24). 
In brief, 2 ×  105 Ficoll-Hypaque purified peripheral blood mononuclear cells as responders and 5 
×  l0  s spleen cells (treated with 2,000 rads before culture) as stimulators were mixed in 200/~l of 
medium in sterile tissue culture microtiter plates (no. 3046, Falcon Plastics, Division of BioQuest, 
Oxnard, Calif.). The medium was RPMI-1640  (Grand Island Biological Co.) containing 100 U/ml 
penicillin, 100  /~g/ml streptomycin, 2 mM v.-glutamine, 25 mM HEPES buffer, and 10% (vol/vol) 
heat-inactivated FCS. Cultures were labeled with [3H]thymidine ([~H]TdR) at 72 h and harvested 
at 90 h.  Responder cells were from C3H/HeN mice or from individual (C3H/HeJ  ×  CBA/J)Ft  x 
C3H/HeJ  backcross  mice.  Stimulater  cells  were  from  (C3H/HeJ  ×  CBA/J)F1  mice  or  from 
individual  (C3H/HeJ  ×  CBA/J)Ft  x  C3H/HeJ  backcross  mice.  All  tests were  performed in 
triplicate. The results are calculated from the uptake of [aH]TdR  and are expressed as the mean 
uptake  of [~H]TdR  in  counts  per  minute  _+  SE  and  as  the stimulation index  (SI  =  cpm of 
experimental/cpm of control). 
Results 
Analysis of B-Lymphocyte  Fc Receptor-Associated  Non-H-2  Antigens of the 
BIO and A/J Strains.  To ascertain how many loci were determining  expres- 
sion  of non-H-2  antigens  which  interact  with  B-cell  Fc receptors,  (B10.A  x 
A/J)F~  x  A/J backcross mice were evaluated for inhibition of binding of aggre- 
gated Ig complexes (which bind primarily to B-lymphocyte Fc receptors, [17]) by 
alloantibodies  against  the  B10 background  (Table I).  Pretreatment  of spleen 
cells with these alloantibodies caused inhibition of binding of Ig complexes (53- 
86%) in 14 of the 29 backcross mice analyzed. This number was not significantly 
different from the 50% expected if B-cell Fc receptor-associated non-H-2 antigens 
were determined by a  single  locus, but was significantly different  (P  <  0.01) 
from the  75% expected if such  antigens  were determined  by two gene loci as 
evaluated by using the individual terms of the binomial distribution.  Thus, B- 
cell  Fc receptor-associated non-H-2  antigens  appeared to be determined  by a 
single  locus,  at  least  in  the  B10  strain.  Inhibition  of binding  was  never 
complete  (53-86%)  and the reasons for this  are not yet known.  However, the 
most likely explanation is that there are other spleen cell populations whose Fc 
receptors  are  not  inhibited  by  these  anti-non-H-2  alloantibodies.  Thus,  a 
similar lack of complete inhibition of binding of Ig complexes to spleen cells by 
anti-Ia  antibodies  was observed (17).  In this  case,  evaluation of purified cell 
populations has revealed that the Fc receptors of nearly all B lymphocytes are 
associated with Ia antigens,  while those of macrophages and the effector cells 
in antibody-dependent cell-mediated cytotoxicity are not (25,  26).  This view is 
further  supported  by the  observation  that  pretreatment  with  alloantibodies 
against  both  H-2  and  non-H-2  antigens  also  does  not  result  in  complete 
inhibition  (data  not  shown).  Spleen  cells  from  the  (B10.A  x  A/J)F~  x  A/J HOWARD  B.  DICKLER,  AFTAB  AHMED,  AND  DAVID  H.  SACHS  1681 
TABLE  ] 
Analysis of (BIO.A  × A/J)F1 x AId Backcross  Mice for B-Lymphocyte Fc Receptor- 
Associated BIO Non-H-2 Antigens, Sex, Coat Color, and Immunoglobulin Allotype 
Animal  Coat  Sex  Ig allotype$ 
no.  color 
Effect of anti-non-H-2 alloantibodies* 
Cytotoxicity 
Percent 
killed§ 
Aggregated Ig Binding][ 
Control  Exp. 
Percent  Percent 
positive  positive 
Inhibition 
% 
351  Black  M  aa  >80  51.0  14.5  72 
352  Black  M  aa  >80  52.0  50.0  4 
353  Black  M  aa  >80  52.0  9.0  83 
355  Black  M  aa.  46  52.5  54.0  -  3 
357  Black  M  aa  >80  52.0  14.0  73 
354  Black  M  ab  40  49.0  50.0  -2 
356  Black  M  ab  >80  50.0  12.0  76 
370  Black  F  aa  >80  39.5  12.0  70 
367  Black  F  ab  >80  52.0  7.5  86 
368  Black  F  ab  >80  40.5  12.0  70 
369  Black  F  ab  >80  53.5  16.5  69 
231  White  M  aa  NT¶  51.0  10.0  81 
362  White  M  aa  >80  47.0  46.5  1 
363  White  M  aa  15  42.0  42.5  -1 
364  White  M  aa  68  41.5  43.5  -5 
365  White  M  aa  78  46.0  47.0  -2 
233  White  F  aa  NT  39.5  40.5  -3 
234  White  F  aa  NT  40.0  44.0  -10 
235  White  F  aa  NT  44.0  I0.0  77 
232  White  F  ab  NT  45.0  8.0  82 
374  White  F  ab  37  46.5  47.0  -1 
445  White  F  ab  26  45.0  44.0  2 
358  Brown  M  aa  >80  44.5  45.0  -1 
359  Brown  M  aa  >80  48.0  45.0  6 
360  Brown  M  ab  >80  47.0  12.0  74 
361  Brown  M  ab  >80  40.0  11.5  71 
372  Brown  F  aa  >80  40.5  39.0  4 
371  Brown  F  ab  >80  40.5  44.0  -9 
373  Brown  F  ab  79  40.5  19.0  53 
* Antibodies  used  were  A/J  anti-B10  except  in  animals  352  and  362  where  A/J  anti-B10.A 
antibodies were used. 
§ The  percent  killed  shown  is  the  highest  percentage  killed  at  any  antibody  concentration. 
Complement and  serum  controls  were  10%  killed  except  for  animals 368,  371,  372,  and  373 
where the complement controls showed 12,  15, 15, and 15% killed,  respectively. 
II  Percent inhibition  Percent positive, control -  percent positive, experimental  =  x  100 
Percent positive, control 
Experimental  =  pretreatment with alloantibodies listed in footnote *. Control  =  pretreatment 
with nonreactive alloantibodies  (B10.A anti-B10). 
¶  NT =  not tested. 
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backcross  mice were  also  analyzed for reactivity with the  anti-B10  non-H-2 
alloantibodies by the microcytotoxicity assay (Table I). It was  apparent that 
these antibodies detected multiple antigens determined by a number of  different 
loci since there was at least partial killing of the spleen cells in 23 of  the 24 mice 
tested. Moreover, in a number of animals (352, 358, 359, 362, 371, and 372) vir- 
tually all the cells were killed in the cytotoxic assay, yet no inhibition was seen 
in the  aggregated Ig binding assay.  This  indicated the presence  of non-H-2 
antigens on B cells which did not interact with Fc receptors. Thus, association 
with B-lymphocyte Fc receptors was a characteristic of some non-H-2 antigens 
present on the B cell but not others. 
These  same  backcross  mice  were  also  evaluated for  sex,  coat  color,  and 
immunoglobulin allotype to determine if  the locus which determines expression 
of B-cell Fc receptor-associated non-H-2 antigens (as determined by inhibition 
of aggregated Ig binding) was linked to either H-1  or the heavy chain allotype 
locus and if sex affected expression (Table I). B-cell Fc receptor-associated non- 
H-2 antigens were present in 11 of 18 pigmented mice (black or brown) and 3 of 
11 albino mice; 8 of 12 mice which inherited Ig allotype from the B10 and 6 of 
17 which did not; and in 7 of 16 males and 7 of 13 females. Since none of these 
percentages were significantly different from 50% as analyzed with the individ- 
ual terms of the binomial distribution, it was concluded that the locus which 
determines expression of B-cell  Fc receptor-associated non-H-2  antigens was 
not linked to H-1 nor to the heavy chain allotype locus, and expression of these 
antigens was neither sex-limited nor an X-linked recessive trait. 
To determine if B-cell Fc receptor-associated non-H-2 antigens were present 
on another background (A/J) (i.e., that such antigens were not unique to the 
B10) and also  determined by a  single  gene  locus,  spleen  cells  from  (A/J  × 
B10.A)F1  ×  B10.A backcross  mice were similarly evaluated for inhibition of 
aggregated Ig binding by pretreatment with anti-A/J non-H-2  alloantibodies 
(Table II).  Inhibition (69-78%)  was observed in 7  of 15  backcross mice.  This 
number was not significantly different from 50% but was significantly (P  < 
0.02) different from 75%. Thus, B-cell Fc receptor-associated non-H-2 antigens 
are present and determined by a single background locus in a second strain (A/ 
J).  It  should  also  be  noted  that  the  Fc  receptors  of B  lymphocytes from 
backcross mice which were not inhibited by anti-A/J non-H-2  alloantibodies 
could be inhibited by pretratment with appropriated alloantibodies (anti-H-2 
which contains anti-Ia). Thus, there was no apparent difference in the B-cell 
Fc receptors themselves.  Additionally, since the alloantibodies used in these 
two backcross experiments (Table I and II) were made in strains with reciprocal 
backgrounds (A/J anti-B10 and B10.A anti-A/J) the results suggest, but do not 
prove, that the B-cell Fc receptor-associated non-H-2 antigens of the B10 and 
A/J are alleles. 
Thus,  analysis of lymphocyte surface antigens determined by background 
genes of the B10  and A/J strains had shown that some non-H-2 antigens but 
not others were associated with B-cell  Fc receptors  and that these  antigens 
were  determined by  a  single  locus  in  each  of these  two  strains.  However, 
linkage  of this  locus  to  another  known  locus  had  not  been  established.  It 
seemed possible  that there  might be  linkage between the Mls  locus  (which HOWARD  B.  DICKLER,  AFTAB  AHMED,  AND  DAVID  H.  SACHS  1683 
TABLE  lI 
Analysis of (A/J × BIO.A)FI x BIO.A Backcross  Mice for B-Lymphocyte Fc Receptor- 
Associated A/J Non-H-2 Antigens 
Animal no. 
Aggregated Ig binding after pretreatment with:* 
Anti-H-2  Anti-non-H-2 
Control 
Percent posi-  Percent posi-  Percent inhi-  Percent posi-  Percent inhi- 
tive 
tive  bition  tive  bition 
596  44.0  13.0  70  44.0  -  1 
597  50.0  12.0  76  48.5  3 
598  49.0  10.0  80  45.0  8 
599  48.5  11.5  76  14.0  71 
600  47.0  12.0  74  14.5  69 
651  47.0  11.5  76  10.5  78 
652  49.5  11.5  77  11.0  78 
653  46.5  8.5  82  45.0  3 
654  39.0  14.0  64  39.5  -1 
655  37.0  9.0  76  36.0  3 
901  47.0  14.5  69  12.0  74 
902  42.0  4.5  89  12.5  70 
903  42.0  8.0  81  12.5  70 
904  48.0  6.0  88  47.0  2 
905  44.0  8.5  81  43.5  1 
* Antibodies used were:  control  =  normal  B10.A;  anti-H-2  =  B10  anti-B10.A;  anti-non-H-2  = 
B10.A anti-A/J. Percent inhibition calculated as described in footnote H, Table I. 
determines the expression of antigens which stimulate in MLC) and the locus 
which determines expression of B-cell Fc receptor-associated non-H-2 antigens, 
since  both  of  these  properties  are  also  characteristics  of  the  Ia  antigens 
determined  by genes  in  the  I  region  of the  H-2  complex.  To  evaluate  this 
possibility,  the  non-H-2  antigens  of yet  another  strain,  the  CBA/J,  were 
analyzed. 
Analysis of B-Lymphocyte Fc Receptor-Associated  Non-H-2  Antigens of the 
CBA/J.  While these studies were in progress, we became aware of the studies 
of Tonkonogy  and  Winn  (27),  which  described  detection  of CBA/J  non-H-2 
antigens (by using a C3H/HeJ anti-CBA/J alloantiserum) which were primarily 
expressed on B cells and peritoneal phagocytic cells, and which were determined 
by a single locus which was linked to the Mls locus. It seemed possible that the 
non-H-2  antigens  which interact  with B-cell Fc receptors and those that they 
described were the same.  Therefore,  C3H/HeJ anti-CBA/J alloantibodies were 
prepared and evaluated for binding to CBA/J spleen cells and for the ability to 
inhibit  binding  of  aggregated  Ig  (Table  HI).  Antigens  detected  by  these 
alloantibodies  were  present  on  53.0%  of the  spleen  cells  as  evaluated  by 
indirect fluorescence by using anti-IgG2 (which does not detect surface Ig). This 
was  a  slightly  higher  percentage  than  the  percentage  of Ig-bearing  B  cells 
(46.0%).  Indirect  fluorescence with  anti-Ig  after  pretreatment  with  the  anti- 
non-H-2  alloantibodies  showed 62.5%  positive cells.  Further,  indirect  fluores- 
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TABLE  III 
C3H/HeJ Anti-CBA/J Alloantibodies Bind to CBA/J B Lymphocytes and Inhibit 
Binding of Ig Complexes to B-Lymphocyte Fc Receptors 
Reagent  Specificity  Anti-Ig stain-  Anti-IgG2  Aggregated Ig 
ing  staining  binding 
% Positive 
Medium  --  46.0  0.5  46.0 
Normal C3H  --  47.0  1.0  45.5 
C3H/HeJ anti-CBA/J  Non-H-2  62.5  53.0  9.0 
B10 anti-B10.BR  H-2  99.0  97.5  14.0 
non-H-2  alloantibodies  showed  approximately  100%  positive  cells  (data  not 
shown). Thus,  it appeared that these antigens were primarily expressed on B- 
lymphocytes.  Preliminary  studies  indicate  they are  also expressed  on spleen 
macrophages  (Carol  O.  Cowing,  David  H.  Sachs,  and  Howard  B.  Dickler, 
unpublished  observations).  Pretreatment  of  CBA/J  spleen  cells  with  these 
alloantibodies  markedly  inhibited the binding  of aggregated  Ig  (80%).  Thus, 
these alloantibodies detected non-H-2 antigens which were associated with B- 
cell  Fc  receptors.  This  observation,  together  with  the  previous  observations 
noted above (27),  suggested that the locus which determines the expression of 
B-lymphocyte Fc receptor-associated non-H-2  antigens  was linked  to the Mls 
locus.  To  confirm this,  spleen  cells from  (C3H/HeJ  x  CBA/J)F1  x  C3H/HeJ 
backcross mice were analyzed for the presence of CBA/J Mls antigens,  and B- 
lymphocyte  Fc  receptor-associated  non-H-2  antigens  (Table  IV).  Of the  29 
animals assessed, 13 were negative for both while 14 were positive for both Fc 
receptor inhibition  by anti-CBA/J  non-H-2  alloantibodies  (48-64%  inhibition) 
and stimulation of C3H/HeN lymphocytes in MLC (SI of 4.7 to 12.9 except for 
mouse M10 which had a  SI of 2.3.  MLC experiments between M10 and  other 
backcross  mice  confirmed  that  this  mouse  did  express  CBA/J  Mls  antigens 
[data not shown]). Two backcross mice (M13 and M16) were positive for CBA/J 
Mls antigens  but negative for B-cell Fc receptor-associated non-H-2 antigens. 
Thus,  CBA/J B-cell Fc receptor-associated non-H-2 antigens  were determined 
by a  single  gene  locus  which  was  linked  but not  identical  to  the  Mls  locus 
(apparent recombination frequency 6.8%). 
Spleen cells from these same backcross mice were also analyzed for reactivity 
with the anti-CBA/J non-H-2 alloantibodies by microcytotoxicity (Table IV). In 
contrast  to  the  A/J  anti-B10  non-H-2  alloantibodies  (see  above),  killing  of 
spleen cells by the C3H/HeJ anti-CBA/J alloantibodies was only observed with 
cells from the same 14 backcross mice whose B-cell Fc receptors were inhibited 
(30-57%  net  kill).  Thus,  the  only  antigens  detected  by these  alloantibodies 
were associated with B-cell Fc receptors or were determined by the same locus. 
This  observation,  together  with  the  fact that  these  antigens  were  expressed 
primarily  on B  cells (see above), made it possible to evaluate whether the B- 
cell Fc receptor-associated non-H-2 antigens might be Fc receptors.  Therefore, 
the  distribution  of these  antigens  was evaluated by indirect  immunofluores- 
cence before and  after capping  of B-lymphocyte-bound antigen-antibody  com- 
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TABLZ  IV 
Analysis of (C3H/HeJ  × CBA/J)F1  x  C3H/HeJ Backcross Mice for B-Lymphocyte Fc 
Receptor-Associated  CBA/J-Non-H-2 Antigens, Sex, and CBA/J Mls Antigens 
Effect of anti-non-H-2 alloantibodies* 
Animal  MLC response  of C3H/HeN  Aggregated Ig Binding 
Mean  uptake of [aH]TdR  Cytotexicity,  percent  killed~ 
Control  Exp. 
Sex  No.  cpm _+  SE  SI  C'  Only  Exp.  Net  Percent pes-  Percent pes-  Percent  in- 
itive  itive  hibition§ 
None  3,257  ±  108 
F  F,  28,119  -+ 1,236  (8.6)  5  44  39  50.0  18.0  64 
F  1  3,954  ±  156  (1.2)  11  12  1  52.0  48.0  8 
F  2  2,994  -+  126  (0.9)  7  15  8  51.5  49.0  5 
F  3  32,416  ±  1,545  (9.9)  11  68  57  50.0  19.0  62 
F  4  3,759  ±  222  (1.1)  11  16  5  48.0  45.0  6 
F  5  4,137  -  114  (1.3)  11  12  1  54.0  52.5  3 
None  4,251  _+  217 
F  F~  41,416  _+  1,982  (9.7)  9  52  43  58.0  24.0  59 
F  6  3,818  ±  273  (0.9)  12  14  2  52.0  56.0  -8 
F  7  4,039  _* 195  (0.9)  4  12  8  57.0  58.0  -2 
F  8  4,543  _+ 268  (1.1)  11  16  5  54.5  52.0  5 
F  9  7,229  _+  1,312  (1.7)  10  14  4  54.5  57.0  -5 
F  10  54,732  _+ 2,413  (12.9)  14  58  44  52.5  21.0  60 
None  3,346  ±  152 
F  F1  35,346  ±  317  (10.9)  11  53  42  50.0  26.0  48 
F  11  4,349  ±  232  (1.3)  9  17  8  50.5  48.5  6 
M  12  37,834  ±  1,852  (11.2)  12  56  44  49.5  22.5  55 
M  13  41,418  _+ 2,019  (12.4)  17  20  3  42.5  41.0  4 
M  14  36,361  _+  1,567  (10.9)  16  64  48  46.0  24.0  48 
M  15  5,357  ±  288  (1.6)  11  12  1  57.0  54.0  5 
M  16  28,876 -+  1,195  (5.6~  16  19  3  49.0  48.5  1 
M  17  4,882  ±  134  (1.5)  16  18  2  43.0  42.0  2 
M  18  5,019  ±  215  (1.5)  18  23  5  38.0  40.0  -5 
M  19  30,085  ±  236  (9.0)  21  75  54  42.5  21.0  51 
None  3,757  ±  154 
F  F~  27,395  ±  1,545  (7.3)  2  47  45  53.0  20.5  61 
M  2  26,419  ±  1,392  (7.0)  11  49  38  39.5  18.0  54 
M  3  28,837  _+ 2,148  (7.7)  7  56  49  48.0  24.0  50 
M  4  4,158  ±  139  (1.I)  5  9  4  47.5  48.0  -1 
M  5  32,657  ±  1,673  (8.7)  13  56  43  53.5  23.0  57 
M  6  21,118  -+  897  (5.6)  8  50  42  49.0  25.0  49 
None  4,276  ±  289 
F  F,  35,351  ±  1,884  (8.4)  8  48  40  50.5  16.0  68 
M  1  31,433  ±  1,546  (7.5)  10  59  49  49.0  23.0  53 
M  7  19,764  ±  857  (4.7)  10  57  47  56.0  20.0  64 
M  8  22,413  _+  711  (5.3)  8  53  45  46.0  18.0  61 
M  9  26,779  ±  1,276  (6.4)  9  39  30  42.0  18.0  57 
M  10  9,714  ±  413  (2.3)  15  51  36  39.5  20.0  49 
* Antibodies used were: control =  normal C3H/HeJ;  experimental  =  C3H/HeJ anti-CBA/J. 
* The percent killed shown is the highest percentage killed at any antibody coneentraOon. 
§ Percent inhibition calculated es described in footnote n, Table 1. 
cells  which  bore them,  the  CBA/J  non-H-2  antigens  remained  unaffected  on 
most cells.  Thus,  at least some of these  B-cell  Fc receptor-associated  non-H-2 
antigens are not identical to Fc receptors. 
The  Locus  Which  Determines  Expression  of B-Lymphocyte  Fc  Receptor- 
Associated Non-H-2 Antigens May be Identical in the BIO and CBA/J Strains. 
Preliminary  strain  distribution  studies  indicated  that  anti-CBA/J  non-H-2 
alloantibodies inhibited the binding of aggregated Ig to spleen cells from B10.A 
but not A/J, and that anti-B10 non-H-2 alloantibodies inhibited the Fc receptors 1686  B-LYMPHOCYTE  Fc  RECEPTOR-ASSOCIATED  NON-H-2  ANTIGENS 
TABLE  V 
Capping of B Lymphocyte-Bound Ag-Ab Complexes Fails to Redistribute CBA/J Non-H-2 B- 
Lymphocyte Fc Receptor-Associated  Antigens* 
Incubation no.  Rhodamine  Fluoreasein 
Percent  Percent  Percent  Percent 
1  25  3  4 
positive  capped§  positive  capped§ 
Medium  Rbodamine  goat  C3H/HeJ  anti-  Fluoreecein goat  0  -  51.0  0 
anti-rabbit Ig  CBA/J  anti-mouse  IgG~ 
and IgG2 
Rabbit anti-TNP-  Rhodamine goat  C3H/HeJ  anti-  Fluorescein goat  61.0  98  55.0  2 
TNP-BSA  anti-rabbit lg  CBA/J  anti-mouse IgG, 
and lgG~ 
* Spleen cells from CBA/J were  used.  The percentage of surface lg-positive cells was 51.0. 
After incubation no. 2 the cells were incubated at 37°C for 15 min to induce capping. Capping was terminated by washing with 4°C 
medium  containing Na azide (0.02%). Incubations no. a and 4 were in the presence of  Na azide to prevent capping. 
§ Cells were considered capped if fluorescence  was detected on less than 50~ of the cell  surface and was at one pole of the cell. Only 
fluorescence-positive  cells  were considered in determining the percent capped. 
of CBA/J but not C3H/HeJ  (data not shown). Thus,  it was possible to deter- 
mine if B-lymphocyte Fc receptor-associated non-H-2 antigens might be deter- 
mined by the same gene locus in these two strains. Spleen cells from (B10.A x 
A/J)F1  x  A/J  and  (C3H/HeJ  x  CBA/J)F1  x  C3H/HeJ backcross  mice  were 
evaluated for inhibition of aggregated Ig binding by pretreatment with anti-B10 
non-H-2 alloantibodies and anti-CBA/J non-H-2 alloantibodies (Tables VI and 
VII).  There was a  perfect correlation of Fc receptor  inhibition by these two 
reagents in both groups of backcross mice, i.e., the B-lymphocyte Fc receptors 
of an individual mouse were either inhibited by both  anti-B10 non-H-2  allo- 
antibodies and anti-CBA/J non-H-2 alloantibodies or by neither. This suggested 
that  the  locus  which determined expression  of B-cell  Fc receptor-associated 
non-H-2 antigens was probably identical in the B10 and CBA/J strains. 
To ascertain if this locus determined B-cell Fc receptor-associated antigen(s) 
which were not shared or crossreactive between the B10 and CBA/J, as well as 
antigen(s)  that  were,  absorption  studies  were  performed.  Anti-B10  non-H-2 
alloantibodies were absorbed with CBA/J spleen cells until no longer reactive 
as evaluated by microcytotoxicity (2  x  10  9 cells/ml), and anti-CBA/J non-H-2 
alloantibodies were absorbed with B10 spleen cells until no longer reactive (1.6 
x  10  9 cells/ml).  The  absorbed  alloantibodies were  then  evaluated for  their 
ability to inhibit binding of aggregated Ig to spleen cells from each of these 
strains  (Table  VIII).  Anti-B10  non-H-2  alloantibodies  absorbed  with  spleen 
cells from CBA/J mice no longer inhibited the B-cell Fc receptors of spleen cells 
from CBA/J mice but continued to inhibit those of spleen cells from B10 mice. 
Similarly, anti-CBA/J non-H-2 alloantibodies absorbed with spleen cells from 
B10  mice did not inhibit binding of Ig complexes to B10  spleen cells but did 
inhibit such binding by CBA/J spleen cells. Thus, each of these two strains had 
at least one antigen which was not shared or crossreactive with the other, and 
at least one antigen which was shared. Moreover, each of the three antigens so 
far detected was associated with B-lymphocyte Fc receptors. 
Discussion 
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TAB~Z VI 
Analysis of (BIO.A  × A/J)FI x A/J Backcross  Mice for Inhibition of B-Lymphocyte Fc 
Receptors  by Alloantibodies against BI O and CBA/J Non-H-2 Antigens 
Aggregate Ig binding after pretreatment with:* 
Anti-B10 non-H°2  Anti-CBA/J non-H-2  Animal no.  Control 
Percent posi- 
tive  Percent posi-  Percent inhi-  Percent posi-  Percent inhi- 
tive  bition  tive  bition 
101  32.0  30.0  6  30.5  5 
102  32.5  32.0  2  34.0  -5 
103  36.0  12.0  67  16.0  56 
104  44.0  41.0  7  44.5  -1 
106  49.0  19.0  61  18.0  63 
107  49.0  50.0  -2  48.0  2 
108  38.0  35.5  7  36.0  5 
109  56.5  56.0  1  52.0  8 
201  49.0  46.0  6  50.0  -  2 
202  44.0  10.5  76  14.0  68 
203  52.0  6.0  88  10.0  $1 
204  52.5  46.0  12  51.0  3 
205  59.5  61.0  -3  62.0  -4 
207  47.0  8.0  83  17.0  64 
208  43.0  42.0  2  41.5  3 
209  42.0  42.5  -  1  41.0  2 
210  38.0  4.5  88  11.5  70 
211  49.5  50.0  -1  47.0  5 
* Antibodies used were: control =  normal C3H/HeJ; anti-B10 non-H-2 =  A/J anti-B10; anti-CBA/ 
J  non-H-2  =  C3H/HeJ  anti-CBA/J.  Percent  inhibition  calculated  as  described  in  footnote II, 
Table I. 
to the Fc receptors of B lymphocytes by alloantibodies against Ia antigens and 
some non-H-2 alloantigens has been previously established (28). The present 
results indicate that this is a  characteristic of antibodies against certain non- 
H-2 alloantigens but not others (including some that are expressed on B cells, 
see  Table  I).  The  B-lymphocyte Fc receptor-associated non-H-2  antigens are 
determined by the gene(s) of a single locus in the three strains that have been 
analyzed  (B10,  A/J,  and  CBAJJ,  see  Tables  I,  II,  and  IV).  Moreover,  the 
observation that at least one such antigen is shared or crossreactive between 
B10  and  CBA/J  and is  present  in the  same backcross  mice which also had 
noncrossreactive antigens suggests that the locus which determines expression 
of B-lymphocyte Fc receptor-associated non-H-2 antigens is identical in these 
two strains (Tables VI and VII). It seems likely that an identical locus will be 
present in all mouse strains. At least four different antigens (one each in A/J, 
B10,  and CBA/J and one which is shared or crossreactive between B10  and 
CBA/J, see Tables II and VIII) have been identified each of which is associated 
with B-cell Fc receptors. This locus is thus polymorphic and may in fact be a 
gene complex. Studies involving strain distribution, absorptions, and chemical 
characterization will be  necessary to further define the  number of antigens 
involved and clarify this point. The antigens involved are expressed primarily 
on  B  lymphocytes,  at  least  in  CBA/J  mice  (Table  HI  and  reference  27). 1688  B-LYMPHOCYTE  Fc  RECEPTOR-ASSOCIATED  NON-H-2  ANTIGENS 
TABLE  VII 
Analysis of (C3H/HeJ  × CBA/J)F1  × C3H/HeJ Backcross Mice for Inhibition of B- 
Lymphocyte Fc Receptors by Alloantibodies against BI O and CBA/J Non-H-2 Antigens 
Animal no. 
Aggregated Ig  binding after  pretreatment with:* 
Anti-CBA/J non-H-2  Anti-B10 non-H-2 
Control 
Percent posi-  Percent posi-  Percent inhi-  Percent posi-  Percent inhi- 
tive  tive  bition  tive  bition 
1  49.0  23.0  53  24.5  50 
2  39.5  18.0  54  19.0  52 
3  48.0  24.0  50  20.0  58 
4  47.5  48.0  -  1  47.0  1 
5  53.5  23.0  57  18.0  66 
6  49.0  25.0  49  26.0  47 
7  56.0  20.0  64  19.5  65 
8  46.0  18.0  61  20.0  57 
9  42.0  18.0  57  21.0  50 
10  39.5  20.0  49  19.0  52 
11  50.5  48.5  6  52.0  -3 
12  49.5  22.5  55  24.0  52 
13  42.5  41.0  4  38.0  11 
14  46.0  24.0  48  22.0  52 
15  57.0  54.0  5  58.0  -2 
16  49.0  48.5  1  50.0  -2 
17  43.0  42.0  2  45.0  -5 
18  38.0  40.0  -5  42.5  -12 
19  42.5  21.0  51  23.0  46 
* Antibodies used were: control =  normal C3H/HeJ; anti-CBA]J non-H-2 =  C3H/HeJ anti-CBA/ 
J; anti-B10 non-H-2 =  A/J anti-B10.A; percent inhibition calculated as described in footnote U, 
Table I. 
TABLZ  VIII 
Several (at Least Three) B-Lymphocyte Fc Receptor-Associated Non-H-2 Antigens are 
Determined by the Single Locus Apparently Common to the BIO and CBA/J Genetic 
Backgrounds 
Exp. no.  Alloantibodies 
Aggregated Ig binding 
B10  CBA/J 
Percent positive 
Normal C3H  52.0 
C3H/HeJ anti-CBA/J  9.0 
C3H/HeJ anti-CBA/J absorbed with B10  51.5 
50.5 
10.5 
17.0 
Normal A/J  50.5  52.0 
A/J anti-B10.A  7.0  14.0 
A/J anti-B10.A absorbed with CBA/J  19.0  50.5 
Absorption  studies  will  be  necessary  to  determine  if this  is  also  true  in  the 
other  strains. 
It is of interest  that  in one  case  (C3H/HeJ  anti-CBA/J  tested  on the  CBA/J 
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were B-lymphocyte Fc receptor-associated, while in another case (A/J anti-B10 
tested on the B10  background) the anti-non-H-2  alloantibodies also detected 
other non-H-2 antigens (including some which were present on B lymphocytes). 
In the latter case, it should be possible to obtain alloantibodies specific for B10 
B-lymphocyte-associated  non-H-2 antigens by absorbing with lymphocytes from 
backcross mice who did not inherit such antigens (see Table I). Alternatively, 
one could breed such mice and use the cells of their progeny. In this fashion, it 
is theoretically possible to obtain alloantibodies specific for B-lymphocyte Fc 
receptor-associated non-H-2 antigens in any strain. 
Capping experiments (Table V)  revealed that at least some of the non-H-2 
antigens which are associated with B-cell Fc receptors are not themselves Fc 
receptors. Since it seems likely that multiple antigens are involved, it remains 
possible that some but not others are Fc receptors. Monospecific alloantibodies 
will be  required to clarify this point.  However,  these  results  are  consistent 
with the possibility that the association is similar to the association between Ia 
antigens and B-cell Fc receptors. Recent distributional and quantitative studies 
have indicated that the latter is probably an interaction induced by the binding 
of ligands to Ia antigens (29). It has been hypothesized that this association 
may play a role in regulation of the immune response (29, 30). 
Linkage studies revealed that the locus which determines expression of B- 
cell ~Fc receptor-associated non-H-2 antigens was not linked to H-1  or the heavy 
chain allotype locus and was neither sex limited nor an X-linked recessive trait 
(Table :D.  However, there was close linkage to the Mls locus (Table IV). This 
locus and the Mls  locus are probably not identical since recombination was 
seen in 2 of 29 animals. Since Tonkonogy and Winn did not observe recombina- 
tion in 42 animals (27), further analysis of backcross mice as well as progeny 
testing of Putative  recombinant animals will be  required  to  determine  the 
exact frequency of recombination. Additional evidence that these loci are not 
identical c0mes from the observation that the B10 and CBA/J share one B-cell 
Fc receptor-associated antigen and yet the B10 Mls locus is nonstimulating (2). 
Finally, recent :strain distribution studies also suggest that these two loci are 
not identical.  ~ 
There are a  variety of similarities between the non-H-2 locus characterized 
in this paper and the H-2-1inked I  region. Both are polymorphic gene systems, 
the products of which are expressed predominantly but not exclusively on the 
B-cell  subpopulation  of :lymphoid cells.  The  products  of both  are  associated 
specifically with  the  B-cell  Fc  receptor,  and  both  are  closely linked  if not 
identical to genes determining MLC stimulatory antigens.  In the  case of Ia 
antigens, several studies have implied that these antigens are identical to the 
MLC  stimulatory antigens  (31, 32), although close  linkage  genetically and 
close association on the cell surface could also explain the data. On the other 
hand, our backcross data, as well as strain distribution, point to close linkage 
but separability of the two comparable non-H-2 loci.  By analogy to the studies 
of MLC stimulation by Ia antigens, it will be of interest to determine whether 
2 S. L. Tonkonogy  and H. J. Winn. 1977. Further genetic and serologic analysis of the Lyre-1 
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or not antibodies to the non-H-2 Mls-associated antigens are capable of blocking 
Mls stimulations. 
This  extensive  similarity  of properties  suggests  that  the  Mls  locus  might 
better  be  termed  the  Mls  complex,  by analogy  to  the  MHC.  Theoretically, 
homology with the I  region of the MHC might imply evolution of this system 
via duplication and translocation of an early (? primordial) I  region gene. If so, 
one might expect structural homologies to be found between the products of the 
Mls complex and the Ia antigens,  something which should be experimentally 
testable.  If structural  homology were indeed found,  it would be important  to 
determine at what point separation  of the two chromosomal regions occurred 
during  evolution,  and  whether  similar  non-MHC-linked  complexes  exist  in 
other species. For example, if such loci exist in man, they could be of importance 
in  tissue  typing.  Such  typing  might  provide  an  important  adjunct  to  HLA 
typing for transplants,  especially of bone marrow in which GVH reactions are 
often seen even after HLA identical grafts. 
Finally,  the definition  of the murine I  region stemmed originally  from the 
detection  of immune  response  (Ir)  genes  determining  responsiveness  to  a 
variety of immunogens.  By analogy,  one might  predict that the Mls  complex 
may  also  be  involved  in  Ir  gene  function.  While  the  majority  of Ir  genes 
studied  to  date  have  been  H-2  linked,  there  have  been  several  responses 
described, the linkage relationships of which have not been determined (3, 4, 8, 
13). Attempts to examine possible linkage between such responses and the Mls 
complex are currently in progress. 
Summary 
Certain  non-H-2  alloantigens  are  associated with  murine  B-lymphocyte Fc 
receptors in that pretreatment of spleen cells with alloantibodies against these 
antigens inhibited binding of Ig complexes to B-cell Fc receptors. This inhibition 
was specific in that:  (a)  as has been shown previously, the Fc portion of the 
alloantibody was not required to produce inhibition; and (b) antibodies against 
some non-H-2 antigens but not antibodies against others (including some that 
were expressed on B cells) caused such inhibition. 
Backcross experiments  revealed that the B-cell Fc receptor-associated non- 
H-2 antigens  were determined by the gene(s) of a  single background locus in 
each of the three  strains  tested  (A/J,  B10,  and  CBA/J).  This  locus was poly- 
morphic  in  that  at  least  four different  B-cell Fc receptor:associated  non-H-2 
antigens were identified (one each in the A/J, B10, and CBAJJ and one antigen 
shared  or  crossreactive  between the  B10  and  CBA/J).  These  antigens  were 
primarily  but not exclusively expressed on  B  lymphocytes as  determined  by 
immunofluorescence studies, and on the basis of capping experiments they did 
not appear to be identical to B-cell Fc receptors. 
Linkage  studies  revealed  that  the  locus which  determined  these  antigens 
was not linked to the albino locus nor the heavy chain allotype locus and expres- 
sion was neither sex-limited nor an X-linked recessive trait. However, this locus 
was closely linked but not identical to the Mls locus (apparent recombination 
frequency 6.8%). 
Thus,  two  closely  linked  non-H-2  loci  both  determine  the  expression  of HOWARD  B.  DICKLER,  AFTAB  AHMED,  AND  DAVID  H.  SACHS  1691 
antigens  which  have  characteristics  similar  to  Ia  antigens.  One  locus  is 
polymorphic and  determines  the  expression  of antigens  which  are  primarily 
expressed  on B  cells  and  are  specifically associated  with  the  Fc receptors of 
these  cells.  The other (Mls  locus) determines antigens which are  stimulatory 
in mixed lymphocyte cultures.  These observations suggest that there may be a 
second gene complex which is the analogue of the I  region of the H-2  complex. 
Received for publication 28 July 1977. 
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